Exactech Launches New Porous Technology for Total Knee Arthroplasty
July 03 2014 - 8:17AM
Business Wire
Supporting Study to be Presented at European
Orthopaedic Research Society Annual Meeting
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, shoulder, spine and
biologic materials, announced today the international launch of
Optetrak Logic® Porous, a new porous technology for total knee
arthroplasty.
Logic Porous offers knee surgeons a new implant coating that
strikes the balance between material strength, pore size and
porosity. Its unique structural lattice developed through layers of
irregular shaped beads results in an increased average pore size
and greater porosity than traditional spherical beads.1
A University of New South Wales animal study compared the Logic
Porous to traditional porous-beaded coating.1 The animal study,
which used an established ovine model, demonstrated: greater shear
strength at the cortical interface after 12 weeks of implantation;
higher overall bone in-growth rates at the cancellous interface
after 12 weeks of implantation; higher total bone in-growth rates
at the cortical interface after four and 12 weeks of implantation;
and greater forgiveness to sub-optimal implantation conditions. The
study will be first presented at the European Orthopaedic Research
Society 22nd Annual Meeting July 2-4.
“The addition of Optetrak Logic Porous strengthens Exactech’s
knee product offerings, demonstrating our continued commitment to
providing our surgeon customers with a comprehensive knee system
that fits their clinical needs,” Exactech CEO David Petty said.
The launch coincides with the 20th anniversary of the Exactech
Knee, a clinically-recognized system of proven implants and
personalized surgical techniques, which includes the Optetrak®
lineage of implants and ExactechGPS® Guided Personalized Surgery.
This is the initial launch of Logic Porous internationally, with
full market availability ramping up throughout 2014 and beyond.
Logic Porous is indicated for cemented use only in the U.S.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
References
1. Data on file at Exactech, Inc.
Exactech, Inc.Investor contactsJody Phillips, 352-377-1140Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888E-mail: exactech@hawkassociates.comorMedia
contactPriscilla Bennett, 352-377-1140Director Marketing
Communication & Public Relations
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Apr 2023 to Apr 2024